nodes	percent_of_prediction	percent_of_DWPC	metapath
Acamprosate—Blood alkaline phosphatase increased—Epirubicin—liver cancer	0.00165	0.00262	CcSEcCtD
Acamprosate—Diabetes mellitus—Epirubicin—liver cancer	0.00165	0.00262	CcSEcCtD
Acamprosate—Gastrointestinal disorder—Sorafenib—liver cancer	0.00164	0.00262	CcSEcCtD
Acamprosate—Constipation—Sorafenib—liver cancer	0.00163	0.0026	CcSEcCtD
Acamprosate—Pain—Sorafenib—liver cancer	0.00163	0.0026	CcSEcCtD
Acamprosate—Eczema—Epirubicin—liver cancer	0.00159	0.00254	CcSEcCtD
Acamprosate—Abnormal vision—Doxorubicin—liver cancer	0.00159	0.00254	CcSEcCtD
Acamprosate—Mental disability—Doxorubicin—liver cancer	0.00158	0.00252	CcSEcCtD
Acamprosate—Gastrointestinal pain—Sorafenib—liver cancer	0.00156	0.00248	CcSEcCtD
Acamprosate—Lymphadenopathy—Doxorubicin—liver cancer	0.00155	0.00248	CcSEcCtD
Acamprosate—Renal failure acute—Epirubicin—liver cancer	0.00155	0.00247	CcSEcCtD
Acamprosate—Phlebitis—Doxorubicin—liver cancer	0.00154	0.00245	CcSEcCtD
Acamprosate—Thrombophlebitis—Doxorubicin—liver cancer	0.00153	0.00244	CcSEcCtD
Acamprosate—Increased appetite—Epirubicin—liver cancer	0.00152	0.00243	CcSEcCtD
Acamprosate—Diabetes mellitus—Doxorubicin—liver cancer	0.00152	0.00243	CcSEcCtD
Acamprosate—Blood alkaline phosphatase increased—Doxorubicin—liver cancer	0.00152	0.00243	CcSEcCtD
Acamprosate—Dermatitis exfoliative—Epirubicin—liver cancer	0.00152	0.00242	CcSEcCtD
Acamprosate—Urticaria—Sorafenib—liver cancer	0.00151	0.00241	CcSEcCtD
Acamprosate—Abdominal pain—Sorafenib—liver cancer	0.0015	0.0024	CcSEcCtD
Acamprosate—Body temperature increased—Sorafenib—liver cancer	0.0015	0.0024	CcSEcCtD
Acamprosate—Dermatitis bullous—Epirubicin—liver cancer	0.0015	0.00239	CcSEcCtD
Acamprosate—Eczema—Doxorubicin—liver cancer	0.00147	0.00235	CcSEcCtD
Acamprosate—Cardiac failure—Epirubicin—liver cancer	0.00147	0.00234	CcSEcCtD
Acamprosate—Hyponatraemia—Epirubicin—liver cancer	0.00144	0.00229	CcSEcCtD
Acamprosate—Renal failure acute—Doxorubicin—liver cancer	0.00143	0.00229	CcSEcCtD
Acamprosate—Gastrointestinal haemorrhage—Epirubicin—liver cancer	0.00143	0.00228	CcSEcCtD
Acamprosate—Diplopia—Epirubicin—liver cancer	0.00143	0.00228	CcSEcCtD
Acamprosate—Increased appetite—Doxorubicin—liver cancer	0.00141	0.00225	CcSEcCtD
Acamprosate—Migraine—Epirubicin—liver cancer	0.00141	0.00225	CcSEcCtD
Acamprosate—Dermatitis exfoliative—Doxorubicin—liver cancer	0.0014	0.00224	CcSEcCtD
Acamprosate—Hypersensitivity—Sorafenib—liver cancer	0.0014	0.00224	CcSEcCtD
Acamprosate—Dermatitis bullous—Doxorubicin—liver cancer	0.00139	0.00221	CcSEcCtD
Acamprosate—Face oedema—Epirubicin—liver cancer	0.00138	0.0022	CcSEcCtD
Acamprosate—Asthenia—Sorafenib—liver cancer	0.00137	0.00218	CcSEcCtD
Acamprosate—Cardiac failure—Doxorubicin—liver cancer	0.00136	0.00216	CcSEcCtD
Acamprosate—Pruritus—Sorafenib—liver cancer	0.00135	0.00215	CcSEcCtD
Acamprosate—Blood creatinine increased—Epirubicin—liver cancer	0.00134	0.00214	CcSEcCtD
Acamprosate—Hyponatraemia—Doxorubicin—liver cancer	0.00133	0.00212	CcSEcCtD
Acamprosate—Gastrointestinal haemorrhage—Doxorubicin—liver cancer	0.00132	0.00211	CcSEcCtD
Acamprosate—Diplopia—Doxorubicin—liver cancer	0.00132	0.00211	CcSEcCtD
Acamprosate—Liver function test abnormal—Epirubicin—liver cancer	0.00132	0.00211	CcSEcCtD
Acamprosate—Dry skin—Epirubicin—liver cancer	0.00131	0.00209	CcSEcCtD
Acamprosate—Orthostatic hypotension—Epirubicin—liver cancer	0.00131	0.00208	CcSEcCtD
Acamprosate—Migraine—Doxorubicin—liver cancer	0.0013	0.00208	CcSEcCtD
Acamprosate—Diarrhoea—Sorafenib—liver cancer	0.0013	0.00208	CcSEcCtD
Acamprosate—Breast disorder—Epirubicin—liver cancer	0.00129	0.00206	CcSEcCtD
Acamprosate—Aspartate aminotransferase increased—Epirubicin—liver cancer	0.00129	0.00206	CcSEcCtD
Acamprosate—Face oedema—Doxorubicin—liver cancer	0.00128	0.00204	CcSEcCtD
Acamprosate—Gastritis—Epirubicin—liver cancer	0.00127	0.00202	CcSEcCtD
Acamprosate—Alanine aminotransferase increased—Epirubicin—liver cancer	0.00126	0.00201	CcSEcCtD
Acamprosate—Dizziness—Sorafenib—liver cancer	0.00126	0.00201	CcSEcCtD
Acamprosate—Abdominal distension—Epirubicin—liver cancer	0.00125	0.00199	CcSEcCtD
Acamprosate—Blood creatinine increased—Doxorubicin—liver cancer	0.00124	0.00198	CcSEcCtD
Acamprosate—Influenza—Epirubicin—liver cancer	0.00124	0.00197	CcSEcCtD
Acamprosate—Asthma—Epirubicin—liver cancer	0.00124	0.00197	CcSEcCtD
Acamprosate—Dysphagia—Epirubicin—liver cancer	0.00124	0.00197	CcSEcCtD
Acamprosate—Eosinophilia—Epirubicin—liver cancer	0.00122	0.00195	CcSEcCtD
Acamprosate—Liver function test abnormal—Doxorubicin—liver cancer	0.00122	0.00195	CcSEcCtD
Acamprosate—Dry skin—Doxorubicin—liver cancer	0.00121	0.00194	CcSEcCtD
Acamprosate—Pancreatitis—Epirubicin—liver cancer	0.00121	0.00193	CcSEcCtD
Acamprosate—Vomiting—Sorafenib—liver cancer	0.00121	0.00193	CcSEcCtD
Acamprosate—Orthostatic hypotension—Doxorubicin—liver cancer	0.00121	0.00193	CcSEcCtD
Acamprosate—Angina pectoris—Epirubicin—liver cancer	0.00121	0.00192	CcSEcCtD
Acamprosate—Rash—Sorafenib—liver cancer	0.0012	0.00191	CcSEcCtD
Acamprosate—Dermatitis—Sorafenib—liver cancer	0.0012	0.00191	CcSEcCtD
Acamprosate—Breast disorder—Doxorubicin—liver cancer	0.0012	0.00191	CcSEcCtD
Acamprosate—Aspartate aminotransferase increased—Doxorubicin—liver cancer	0.00119	0.0019	CcSEcCtD
Acamprosate—Headache—Sorafenib—liver cancer	0.00119	0.0019	CcSEcCtD
Acamprosate—Bronchitis—Epirubicin—liver cancer	0.00119	0.0019	CcSEcCtD
Acamprosate—Gastritis—Doxorubicin—liver cancer	0.00117	0.00187	CcSEcCtD
Acamprosate—Alanine aminotransferase increased—Doxorubicin—liver cancer	0.00117	0.00186	CcSEcCtD
Acamprosate—Abdominal distension—Doxorubicin—liver cancer	0.00115	0.00184	CcSEcCtD
Acamprosate—Influenza—Doxorubicin—liver cancer	0.00114	0.00183	CcSEcCtD
Acamprosate—Asthma—Doxorubicin—liver cancer	0.00114	0.00183	CcSEcCtD
Acamprosate—Dysphagia—Doxorubicin—liver cancer	0.00114	0.00183	CcSEcCtD
Acamprosate—Pollakiuria—Epirubicin—liver cancer	0.00114	0.00182	CcSEcCtD
Acamprosate—Eosinophilia—Doxorubicin—liver cancer	0.00113	0.00181	CcSEcCtD
Acamprosate—Nausea—Sorafenib—liver cancer	0.00113	0.0018	CcSEcCtD
Acamprosate—Photosensitivity reaction—Epirubicin—liver cancer	0.00113	0.0018	CcSEcCtD
Acamprosate—Weight increased—Epirubicin—liver cancer	0.00113	0.0018	CcSEcCtD
Acamprosate—Pancreatitis—Doxorubicin—liver cancer	0.00112	0.00179	CcSEcCtD
Acamprosate—Weight decreased—Epirubicin—liver cancer	0.00112	0.00178	CcSEcCtD
Acamprosate—Hyperglycaemia—Epirubicin—liver cancer	0.00112	0.00178	CcSEcCtD
Acamprosate—Angina pectoris—Doxorubicin—liver cancer	0.00111	0.00178	CcSEcCtD
Acamprosate—Pneumonia—Epirubicin—liver cancer	0.00111	0.00177	CcSEcCtD
Acamprosate—Bronchitis—Doxorubicin—liver cancer	0.0011	0.00176	CcSEcCtD
Acamprosate—Stomatitis—Epirubicin—liver cancer	0.00108	0.00171	CcSEcCtD
Acamprosate—Urinary tract infection—Epirubicin—liver cancer	0.00107	0.00171	CcSEcCtD
Acamprosate—Sweating—Epirubicin—liver cancer	0.00106	0.00169	CcSEcCtD
Acamprosate—Pollakiuria—Doxorubicin—liver cancer	0.00106	0.00169	CcSEcCtD
Acamprosate—Haematuria—Epirubicin—liver cancer	0.00105	0.00168	CcSEcCtD
Acamprosate—Photosensitivity reaction—Doxorubicin—liver cancer	0.00104	0.00167	CcSEcCtD
Acamprosate—Weight increased—Doxorubicin—liver cancer	0.00104	0.00166	CcSEcCtD
Acamprosate—Epistaxis—Epirubicin—liver cancer	0.00104	0.00166	CcSEcCtD
Acamprosate—Weight decreased—Doxorubicin—liver cancer	0.00104	0.00165	CcSEcCtD
Acamprosate—Hyperglycaemia—Doxorubicin—liver cancer	0.00103	0.00165	CcSEcCtD
Acamprosate—Pneumonia—Doxorubicin—liver cancer	0.00103	0.00164	CcSEcCtD
Acamprosate—Haemoglobin—Epirubicin—liver cancer	0.000995	0.00159	CcSEcCtD
Acamprosate—Stomatitis—Doxorubicin—liver cancer	0.000995	0.00159	CcSEcCtD
Acamprosate—Rhinitis—Epirubicin—liver cancer	0.000993	0.00158	CcSEcCtD
Acamprosate—Urinary tract infection—Doxorubicin—liver cancer	0.000992	0.00158	CcSEcCtD
Acamprosate—Hepatitis—Epirubicin—liver cancer	0.00099	0.00158	CcSEcCtD
Acamprosate—Haemorrhage—Epirubicin—liver cancer	0.00099	0.00158	CcSEcCtD
Acamprosate—Hypoaesthesia—Epirubicin—liver cancer	0.000985	0.00157	CcSEcCtD
Acamprosate—Pharyngitis—Epirubicin—liver cancer	0.000983	0.00157	CcSEcCtD
Acamprosate—Sweating—Doxorubicin—liver cancer	0.000978	0.00156	CcSEcCtD
Acamprosate—Oedema peripheral—Epirubicin—liver cancer	0.000975	0.00156	CcSEcCtD
Acamprosate—Haematuria—Doxorubicin—liver cancer	0.000973	0.00155	CcSEcCtD
Acamprosate—Epistaxis—Doxorubicin—liver cancer	0.000963	0.00154	CcSEcCtD
Acamprosate—Visual impairment—Epirubicin—liver cancer	0.000954	0.00152	CcSEcCtD
Acamprosate—Tinnitus—Epirubicin—liver cancer	0.000923	0.00147	CcSEcCtD
Acamprosate—Haemoglobin—Doxorubicin—liver cancer	0.000921	0.00147	CcSEcCtD
Acamprosate—Rhinitis—Doxorubicin—liver cancer	0.000919	0.00146	CcSEcCtD
Acamprosate—Haemorrhage—Doxorubicin—liver cancer	0.000916	0.00146	CcSEcCtD
Acamprosate—Hepatitis—Doxorubicin—liver cancer	0.000916	0.00146	CcSEcCtD
Acamprosate—Hypoaesthesia—Doxorubicin—liver cancer	0.000912	0.00145	CcSEcCtD
Acamprosate—Pharyngitis—Doxorubicin—liver cancer	0.000909	0.00145	CcSEcCtD
Acamprosate—Oedema peripheral—Doxorubicin—liver cancer	0.000903	0.00144	CcSEcCtD
Acamprosate—Immune system disorder—Epirubicin—liver cancer	0.000894	0.00143	CcSEcCtD
Acamprosate—Chills—Epirubicin—liver cancer	0.000888	0.00142	CcSEcCtD
Acamprosate—Visual impairment—Doxorubicin—liver cancer	0.000883	0.00141	CcSEcCtD
Acamprosate—Alopecia—Epirubicin—liver cancer	0.000875	0.0014	CcSEcCtD
Acamprosate—Mental disorder—Epirubicin—liver cancer	0.000867	0.00138	CcSEcCtD
Acamprosate—Malnutrition—Epirubicin—liver cancer	0.000862	0.00137	CcSEcCtD
Acamprosate—Tinnitus—Doxorubicin—liver cancer	0.000854	0.00136	CcSEcCtD
Acamprosate—Flatulence—Epirubicin—liver cancer	0.000849	0.00135	CcSEcCtD
Acamprosate—Tension—Epirubicin—liver cancer	0.000846	0.00135	CcSEcCtD
Acamprosate—Dysgeusia—Epirubicin—liver cancer	0.000844	0.00135	CcSEcCtD
Acamprosate—Nervousness—Epirubicin—liver cancer	0.000837	0.00133	CcSEcCtD
Acamprosate—Back pain—Epirubicin—liver cancer	0.000834	0.00133	CcSEcCtD
Acamprosate—Muscle spasms—Epirubicin—liver cancer	0.000829	0.00132	CcSEcCtD
Acamprosate—Immune system disorder—Doxorubicin—liver cancer	0.000828	0.00132	CcSEcCtD
Acamprosate—Chills—Doxorubicin—liver cancer	0.000822	0.00131	CcSEcCtD
Acamprosate—Alopecia—Doxorubicin—liver cancer	0.00081	0.00129	CcSEcCtD
Acamprosate—Mental disorder—Doxorubicin—liver cancer	0.000803	0.00128	CcSEcCtD
Acamprosate—Ill-defined disorder—Epirubicin—liver cancer	0.0008	0.00128	CcSEcCtD
Acamprosate—Malnutrition—Doxorubicin—liver cancer	0.000798	0.00127	CcSEcCtD
Acamprosate—Anaemia—Epirubicin—liver cancer	0.000797	0.00127	CcSEcCtD
Acamprosate—Agitation—Epirubicin—liver cancer	0.000792	0.00126	CcSEcCtD
Acamprosate—Flatulence—Doxorubicin—liver cancer	0.000786	0.00125	CcSEcCtD
Acamprosate—Tension—Doxorubicin—liver cancer	0.000783	0.00125	CcSEcCtD
Acamprosate—Dysgeusia—Doxorubicin—liver cancer	0.000781	0.00125	CcSEcCtD
Acamprosate—Malaise—Epirubicin—liver cancer	0.000777	0.00124	CcSEcCtD
Acamprosate—Nervousness—Doxorubicin—liver cancer	0.000775	0.00124	CcSEcCtD
Acamprosate—Vertigo—Epirubicin—liver cancer	0.000774	0.00123	CcSEcCtD
Acamprosate—Syncope—Epirubicin—liver cancer	0.000773	0.00123	CcSEcCtD
Acamprosate—Leukopenia—Epirubicin—liver cancer	0.000772	0.00123	CcSEcCtD
Acamprosate—Back pain—Doxorubicin—liver cancer	0.000771	0.00123	CcSEcCtD
Acamprosate—Muscle spasms—Doxorubicin—liver cancer	0.000767	0.00122	CcSEcCtD
Acamprosate—Palpitations—Epirubicin—liver cancer	0.000762	0.00121	CcSEcCtD
Acamprosate—Loss of consciousness—Epirubicin—liver cancer	0.000758	0.00121	CcSEcCtD
Acamprosate—Cough—Epirubicin—liver cancer	0.000752	0.0012	CcSEcCtD
Acamprosate—Convulsion—Epirubicin—liver cancer	0.000747	0.00119	CcSEcCtD
Acamprosate—Hypertension—Epirubicin—liver cancer	0.000744	0.00119	CcSEcCtD
Acamprosate—Ill-defined disorder—Doxorubicin—liver cancer	0.00074	0.00118	CcSEcCtD
Acamprosate—Anaemia—Doxorubicin—liver cancer	0.000737	0.00118	CcSEcCtD
Acamprosate—Myalgia—Epirubicin—liver cancer	0.000734	0.00117	CcSEcCtD
Acamprosate—Chest pain—Epirubicin—liver cancer	0.000734	0.00117	CcSEcCtD
Acamprosate—Arthralgia—Epirubicin—liver cancer	0.000734	0.00117	CcSEcCtD
Acamprosate—Agitation—Doxorubicin—liver cancer	0.000733	0.00117	CcSEcCtD
Acamprosate—Anxiety—Epirubicin—liver cancer	0.000731	0.00117	CcSEcCtD
Acamprosate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.000729	0.00116	CcSEcCtD
Acamprosate—Discomfort—Epirubicin—liver cancer	0.000725	0.00116	CcSEcCtD
Acamprosate—Malaise—Doxorubicin—liver cancer	0.000719	0.00115	CcSEcCtD
Acamprosate—Dry mouth—Epirubicin—liver cancer	0.000718	0.00114	CcSEcCtD
Acamprosate—Vertigo—Doxorubicin—liver cancer	0.000717	0.00114	CcSEcCtD
Acamprosate—Syncope—Doxorubicin—liver cancer	0.000715	0.00114	CcSEcCtD
Acamprosate—Leukopenia—Doxorubicin—liver cancer	0.000714	0.00114	CcSEcCtD
Acamprosate—Confusional state—Epirubicin—liver cancer	0.000709	0.00113	CcSEcCtD
Acamprosate—Palpitations—Doxorubicin—liver cancer	0.000705	0.00112	CcSEcCtD
Acamprosate—Anaphylactic shock—Epirubicin—liver cancer	0.000703	0.00112	CcSEcCtD
Acamprosate—Loss of consciousness—Doxorubicin—liver cancer	0.000701	0.00112	CcSEcCtD
Acamprosate—Infection—Epirubicin—liver cancer	0.000699	0.00111	CcSEcCtD
Acamprosate—Cough—Doxorubicin—liver cancer	0.000696	0.00111	CcSEcCtD
Acamprosate—Shock—Epirubicin—liver cancer	0.000692	0.0011	CcSEcCtD
Acamprosate—Convulsion—Doxorubicin—liver cancer	0.000691	0.0011	CcSEcCtD
Acamprosate—Thrombocytopenia—Epirubicin—liver cancer	0.000689	0.0011	CcSEcCtD
Acamprosate—Hypertension—Doxorubicin—liver cancer	0.000689	0.0011	CcSEcCtD
Acamprosate—Tachycardia—Epirubicin—liver cancer	0.000687	0.00109	CcSEcCtD
Acamprosate—Skin disorder—Epirubicin—liver cancer	0.000683	0.00109	CcSEcCtD
Acamprosate—Hyperhidrosis—Epirubicin—liver cancer	0.00068	0.00108	CcSEcCtD
Acamprosate—Arthralgia—Doxorubicin—liver cancer	0.000679	0.00108	CcSEcCtD
Acamprosate—Chest pain—Doxorubicin—liver cancer	0.000679	0.00108	CcSEcCtD
Acamprosate—Myalgia—Doxorubicin—liver cancer	0.000679	0.00108	CcSEcCtD
Acamprosate—Anxiety—Doxorubicin—liver cancer	0.000677	0.00108	CcSEcCtD
Acamprosate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.000674	0.00108	CcSEcCtD
Acamprosate—Discomfort—Doxorubicin—liver cancer	0.000671	0.00107	CcSEcCtD
Acamprosate—Anorexia—Epirubicin—liver cancer	0.000671	0.00107	CcSEcCtD
Acamprosate—Dry mouth—Doxorubicin—liver cancer	0.000664	0.00106	CcSEcCtD
Acamprosate—Hypotension—Epirubicin—liver cancer	0.000657	0.00105	CcSEcCtD
Acamprosate—Confusional state—Doxorubicin—liver cancer	0.000656	0.00105	CcSEcCtD
Acamprosate—Anaphylactic shock—Doxorubicin—liver cancer	0.000651	0.00104	CcSEcCtD
Acamprosate—Infection—Doxorubicin—liver cancer	0.000647	0.00103	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000641	0.00102	CcSEcCtD
Acamprosate—Shock—Doxorubicin—liver cancer	0.00064	0.00102	CcSEcCtD
Acamprosate—Thrombocytopenia—Doxorubicin—liver cancer	0.000637	0.00102	CcSEcCtD
Acamprosate—Insomnia—Epirubicin—liver cancer	0.000636	0.00101	CcSEcCtD
Acamprosate—Tachycardia—Doxorubicin—liver cancer	0.000635	0.00101	CcSEcCtD
Acamprosate—Skin disorder—Doxorubicin—liver cancer	0.000632	0.00101	CcSEcCtD
Acamprosate—Paraesthesia—Epirubicin—liver cancer	0.000632	0.00101	CcSEcCtD
Acamprosate—Hyperhidrosis—Doxorubicin—liver cancer	0.000629	0.001	CcSEcCtD
Acamprosate—Dyspnoea—Epirubicin—liver cancer	0.000627	0.001	CcSEcCtD
Acamprosate—Somnolence—Epirubicin—liver cancer	0.000625	0.000997	CcSEcCtD
Acamprosate—Anorexia—Doxorubicin—liver cancer	0.00062	0.000989	CcSEcCtD
Acamprosate—Dyspepsia—Epirubicin—liver cancer	0.000619	0.000987	CcSEcCtD
Acamprosate—Decreased appetite—Epirubicin—liver cancer	0.000612	0.000975	CcSEcCtD
Acamprosate—Hypotension—Doxorubicin—liver cancer	0.000608	0.00097	CcSEcCtD
Acamprosate—Gastrointestinal disorder—Epirubicin—liver cancer	0.000607	0.000968	CcSEcCtD
Acamprosate—Constipation—Epirubicin—liver cancer	0.000602	0.000959	CcSEcCtD
Acamprosate—Pain—Epirubicin—liver cancer	0.000602	0.000959	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000593	0.000946	CcSEcCtD
Acamprosate—Insomnia—Doxorubicin—liver cancer	0.000589	0.000939	CcSEcCtD
Acamprosate—Paraesthesia—Doxorubicin—liver cancer	0.000584	0.000932	CcSEcCtD
Acamprosate—Dyspnoea—Doxorubicin—liver cancer	0.00058	0.000925	CcSEcCtD
Acamprosate—Feeling abnormal—Epirubicin—liver cancer	0.00058	0.000924	CcSEcCtD
Acamprosate—Somnolence—Doxorubicin—liver cancer	0.000579	0.000923	CcSEcCtD
Acamprosate—Gastrointestinal pain—Epirubicin—liver cancer	0.000575	0.000917	CcSEcCtD
Acamprosate—Dyspepsia—Doxorubicin—liver cancer	0.000573	0.000914	CcSEcCtD
Acamprosate—Decreased appetite—Doxorubicin—liver cancer	0.000566	0.000902	CcSEcCtD
Acamprosate—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000562	0.000896	CcSEcCtD
Acamprosate—Urticaria—Epirubicin—liver cancer	0.000559	0.000891	CcSEcCtD
Acamprosate—Pain—Doxorubicin—liver cancer	0.000557	0.000888	CcSEcCtD
Acamprosate—Constipation—Doxorubicin—liver cancer	0.000557	0.000888	CcSEcCtD
Acamprosate—Abdominal pain—Epirubicin—liver cancer	0.000556	0.000887	CcSEcCtD
Acamprosate—Body temperature increased—Epirubicin—liver cancer	0.000556	0.000887	CcSEcCtD
Acamprosate—Feeling abnormal—Doxorubicin—liver cancer	0.000536	0.000855	CcSEcCtD
Acamprosate—Gastrointestinal pain—Doxorubicin—liver cancer	0.000532	0.000849	CcSEcCtD
Acamprosate—Hypersensitivity—Epirubicin—liver cancer	0.000518	0.000826	CcSEcCtD
Acamprosate—Urticaria—Doxorubicin—liver cancer	0.000517	0.000825	CcSEcCtD
Acamprosate—Body temperature increased—Doxorubicin—liver cancer	0.000515	0.000821	CcSEcCtD
Acamprosate—Abdominal pain—Doxorubicin—liver cancer	0.000515	0.000821	CcSEcCtD
Acamprosate—Asthenia—Epirubicin—liver cancer	0.000505	0.000805	CcSEcCtD
Acamprosate—Pruritus—Epirubicin—liver cancer	0.000498	0.000794	CcSEcCtD
Acamprosate—Diarrhoea—Epirubicin—liver cancer	0.000481	0.000768	CcSEcCtD
Acamprosate—Hypersensitivity—Doxorubicin—liver cancer	0.00048	0.000765	CcSEcCtD
Acamprosate—Asthenia—Doxorubicin—liver cancer	0.000467	0.000745	CcSEcCtD
Acamprosate—Dizziness—Epirubicin—liver cancer	0.000465	0.000742	CcSEcCtD
Acamprosate—Pruritus—Doxorubicin—liver cancer	0.000461	0.000734	CcSEcCtD
Acamprosate—Vomiting—Epirubicin—liver cancer	0.000447	0.000713	CcSEcCtD
Acamprosate—Diarrhoea—Doxorubicin—liver cancer	0.000445	0.00071	CcSEcCtD
Acamprosate—Rash—Epirubicin—liver cancer	0.000444	0.000707	CcSEcCtD
Acamprosate—Dermatitis—Epirubicin—liver cancer	0.000443	0.000707	CcSEcCtD
Acamprosate—Headache—Epirubicin—liver cancer	0.000441	0.000703	CcSEcCtD
Acamprosate—GABRG2—Transmembrane transport of small molecules—SLC40A1—liver cancer	0.000439	0.00118	CbGpPWpGaD
Acamprosate—GRM5—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—liver cancer	0.000438	0.00117	CbGpPWpGaD
Acamprosate—GRIN1—Alzheimers Disease—TP53—liver cancer	0.000434	0.00116	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—ABL1—liver cancer	0.000434	0.00116	CbGpPWpGaD
Acamprosate—Dizziness—Doxorubicin—liver cancer	0.00043	0.000686	CcSEcCtD
Acamprosate—GRM5—GPCR downstream signaling—CSF2—liver cancer	0.00043	0.00115	CbGpPWpGaD
Acamprosate—GRIN1—Transmission across Chemical Synapses—BRAF—liver cancer	0.00043	0.00115	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—ANXA2—liver cancer	0.000429	0.00115	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—ATP7B—liver cancer	0.000429	0.00115	CbGpPWpGaD
Acamprosate—GRIN2B—Alzheimers Disease—TP53—liver cancer	0.000423	0.00114	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—MAPK14—liver cancer	0.000423	0.00113	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—ATP7B—liver cancer	0.000421	0.00113	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—ANXA2—liver cancer	0.000421	0.00113	CbGpPWpGaD
Acamprosate—GRIN1—BDNF signaling pathway—CASP3—liver cancer	0.000419	0.00112	CbGpPWpGaD
Acamprosate—GRM5—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—liver cancer	0.000419	0.00112	CbGpPWpGaD
Acamprosate—GRIN2B—Transmission across Chemical Synapses—BRAF—liver cancer	0.000419	0.00112	CbGpPWpGaD
Acamprosate—Nausea—Epirubicin—liver cancer	0.000418	0.000666	CcSEcCtD
Acamprosate—Vomiting—Doxorubicin—liver cancer	0.000414	0.00066	CcSEcCtD
Acamprosate—GRIN2C—Neuronal System—RAF1—liver cancer	0.000413	0.00111	CbGpPWpGaD
Acamprosate—GRIN2A—Transmission across Chemical Synapses—RAF1—liver cancer	0.000411	0.0011	CbGpPWpGaD
Acamprosate—Rash—Doxorubicin—liver cancer	0.00041	0.000654	CcSEcCtD
Acamprosate—Dermatitis—Doxorubicin—liver cancer	0.00041	0.000654	CcSEcCtD
Acamprosate—GRIN2B—BDNF signaling pathway—CASP3—liver cancer	0.000408	0.0011	CbGpPWpGaD
Acamprosate—Headache—Doxorubicin—liver cancer	0.000408	0.00065	CcSEcCtD
Acamprosate—GRIN1—BDNF signaling pathway—JUN—liver cancer	0.000407	0.00109	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—NR1H4—liver cancer	0.000405	0.00109	CbGpPWpGaD
Acamprosate—GRIN1—BDNF signaling pathway—CTNNB1—liver cancer	0.000404	0.00108	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—SLC11A2—liver cancer	0.000402	0.00108	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—NR1H4—liver cancer	0.000398	0.00107	CbGpPWpGaD
Acamprosate—GRIN2B—BDNF signaling pathway—JUN—liver cancer	0.000397	0.00106	CbGpPWpGaD
Acamprosate—GRIN2C—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—liver cancer	0.000395	0.00106	CbGpPWpGaD
Acamprosate—GRIN2B—BDNF signaling pathway—CTNNB1—liver cancer	0.000394	0.00106	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—CASP3—liver cancer	0.000393	0.00105	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—APC—liver cancer	0.000392	0.00105	CbGpPWpGaD
Acamprosate—SLC36A1—Transmembrane transport of small molecules—PPARA—liver cancer	0.000391	0.00105	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—CSF2—liver cancer	0.00039	0.00105	CbGpPWpGaD
Acamprosate—Nausea—Doxorubicin—liver cancer	0.000387	0.000617	CcSEcCtD
Acamprosate—GRIN1—BDNF signaling pathway—MAPK8—liver cancer	0.000385	0.00103	CbGpPWpGaD
Acamprosate—GRIN2D—Neuronal System—RAF1—liver cancer	0.000384	0.00103	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—SLC40A1—liver cancer	0.000384	0.00103	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—MYC—liver cancer	0.000384	0.00103	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—TGFB1—liver cancer	0.000383	0.00103	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—JUN—liver cancer	0.000382	0.00102	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—CTNNB1—liver cancer	0.000379	0.00102	CbGpPWpGaD
Acamprosate—GRIN2A—Neuronal System—BRAF—liver cancer	0.000377	0.00101	CbGpPWpGaD
Acamprosate—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—liver cancer	0.000377	0.00101	CbGpPWpGaD
Acamprosate—GRIN2B—BDNF signaling pathway—MAPK8—liver cancer	0.000375	0.00101	CbGpPWpGaD
Acamprosate—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—liver cancer	0.00037	0.000993	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—ANXA2—liver cancer	0.000368	0.000986	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—ATP7B—liver cancer	0.000368	0.000986	CbGpPWpGaD
Acamprosate—GRIN2D—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—liver cancer	0.000367	0.000984	CbGpPWpGaD
Acamprosate—GRIN1—EPH-Ephrin signaling—HRAS—liver cancer	0.000361	0.000969	CbGpPWpGaD
Acamprosate—GRIN1—Transmission across Chemical Synapses—RAF1—liver cancer	0.000359	0.000962	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—ADAM17—liver cancer	0.000358	0.00096	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—TNF—liver cancer	0.000357	0.000958	CbGpPWpGaD
Acamprosate—GRIN2B—EPH-Ephrin signaling—HRAS—liver cancer	0.000352	0.000945	CbGpPWpGaD
Acamprosate—GRIN1—BDNF signaling pathway—STAT3—liver cancer	0.000352	0.000944	CbGpPWpGaD
Acamprosate—GRIN2B—Transmission across Chemical Synapses—RAF1—liver cancer	0.00035	0.000938	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—NR1H4—liver cancer	0.000348	0.000933	CbGpPWpGaD
Acamprosate—GRIN2B—BDNF signaling pathway—STAT3—liver cancer	0.000343	0.00092	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—KDR—liver cancer	0.000337	0.000905	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—F2—liver cancer	0.000337	0.000904	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PSMA4—liver cancer	0.000336	0.000902	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PSMD10—liver cancer	0.000336	0.000902	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—VEGFA—liver cancer	0.000334	0.000894	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—MET—liver cancer	0.00033	0.000885	CbGpPWpGaD
Acamprosate—GRIN1—Neuronal System—BRAF—liver cancer	0.000329	0.000883	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—KDR—liver cancer	0.000329	0.000882	CbGpPWpGaD
Acamprosate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—liver cancer	0.000324	0.000868	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—PIK3CG—liver cancer	0.000323	0.000866	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—MET—liver cancer	0.000322	0.000863	CbGpPWpGaD
Acamprosate—GRIN2B—Neuronal System—BRAF—liver cancer	0.000321	0.000861	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—ABL1—liver cancer	0.000318	0.000852	CbGpPWpGaD
Acamprosate—GRIN2A—Neuronal System—RAF1—liver cancer	0.000315	0.000845	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—TP53—liver cancer	0.000315	0.000845	CbGpPWpGaD
Acamprosate—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—liver cancer	0.000315	0.000844	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—ABL1—liver cancer	0.00031	0.00083	CbGpPWpGaD
Acamprosate—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—liver cancer	0.000309	0.000829	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—RAF1—liver cancer	0.000308	0.000826	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—F2—liver cancer	0.000306	0.000821	CbGpPWpGaD
Acamprosate—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—liver cancer	0.000301	0.000808	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—MTOR—liver cancer	0.000301	0.000806	CbGpPWpGaD
Acamprosate—GRIN2C—Transmission across Chemical Synapses—HRAS—liver cancer	0.000297	0.000796	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—PIK3CG—liver cancer	0.000293	0.000786	CbGpPWpGaD
Acamprosate—SLC36A1—Transmembrane transport of small molecules—ALB—liver cancer	0.000291	0.00078	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—IL6—liver cancer	0.000288	0.000773	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—TNF—liver cancer	0.000286	0.000767	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—PIK3CD—liver cancer	0.000284	0.000761	CbGpPWpGaD
Acamprosate—GABRB3—Transmission across Chemical Synapses—BRAF—liver cancer	0.000283	0.00076	CbGpPWpGaD
Acamprosate—GABRB3—Ion channel transport—RAF1—liver cancer	0.00028	0.000751	CbGpPWpGaD
Acamprosate—GABRG2—Transmission across Chemical Synapses—BRAF—liver cancer	0.000278	0.000746	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—CASP3—liver cancer	0.000276	0.000741	CbGpPWpGaD
Acamprosate—GRIN2D—Transmission across Chemical Synapses—HRAS—liver cancer	0.000276	0.00074	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—MMP2—liver cancer	0.000275	0.000738	CbGpPWpGaD
Acamprosate—GABRG2—Ion channel transport—RAF1—liver cancer	0.000275	0.000738	CbGpPWpGaD
Acamprosate—GRIN1—Neuronal System—RAF1—liver cancer	0.000275	0.000737	CbGpPWpGaD
Acamprosate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—liver cancer	0.00027	0.000725	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—JUN—liver cancer	0.000268	0.00072	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—MMP2—liver cancer	0.000268	0.00072	CbGpPWpGaD
Acamprosate—GRIN2B—Neuronal System—RAF1—liver cancer	0.000268	0.000719	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—CTNNB1—liver cancer	0.000266	0.000715	CbGpPWpGaD
Acamprosate—SLC36A1—Transmembrane transport of small molecules—RAF1—liver cancer	0.000263	0.000705	CbGpPWpGaD
Acamprosate—GRIN1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—liver cancer	0.000263	0.000705	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PRKCE—liver cancer	0.000261	0.000699	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—PPARA—liver cancer	0.000259	0.000694	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—PIK3CD—liver cancer	0.000258	0.000691	CbGpPWpGaD
Acamprosate—GRIN1—BDNF signaling pathway—HRAS—liver cancer	0.000257	0.000689	CbGpPWpGaD
Acamprosate—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—liver cancer	0.000256	0.000687	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—MAPK8—liver cancer	0.000254	0.000681	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—PPARA—liver cancer	0.000252	0.000677	CbGpPWpGaD
Acamprosate—GRIN2B—BDNF signaling pathway—HRAS—liver cancer	0.00025	0.000672	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—PIK3CB—liver cancer	0.000247	0.000663	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—IGF2—liver cancer	0.000247	0.000662	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—RAF1—liver cancer	0.000244	0.000654	CbGpPWpGaD
Acamprosate—GABRA1—Transmission across Chemical Synapses—BRAF—liver cancer	0.000243	0.000652	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—KDR—liver cancer	0.000241	0.000646	CbGpPWpGaD
Acamprosate—GABRA1—Ion channel transport—RAF1—liver cancer	0.00024	0.000645	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—MAPK14—liver cancer	0.000239	0.000641	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—RAF1—liver cancer	0.000238	0.000638	CbGpPWpGaD
Acamprosate—GABRB3—Transmission across Chemical Synapses—RAF1—liver cancer	0.000237	0.000635	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—MET—liver cancer	0.000236	0.000632	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—KDR—liver cancer	0.000235	0.000629	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—MAPK14—liver cancer	0.000233	0.000625	CbGpPWpGaD
Acamprosate—GABRG2—Transmission across Chemical Synapses—RAF1—liver cancer	0.000232	0.000623	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—STAT3—liver cancer	0.000232	0.000623	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—IL6—liver cancer	0.000231	0.000619	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CSF2—liver cancer	0.000231	0.000618	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—RAF1—liver cancer	0.00023	0.000617	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—MET—liver cancer	0.00023	0.000616	CbGpPWpGaD
Acamprosate—GRIN2C—Neuronal System—HRAS—liver cancer	0.000227	0.00061	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—H2AFX—liver cancer	0.000227	0.000609	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—IL2—liver cancer	0.000227	0.000609	CbGpPWpGaD
Acamprosate—GRIN1—BDNF signaling pathway—AKT1—liver cancer	0.000227	0.000608	CbGpPWpGaD
Acamprosate—GRIN2A—Transmission across Chemical Synapses—HRAS—liver cancer	0.000226	0.000607	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—PIK3CB—liver cancer	0.000225	0.000602	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—CASP3—liver cancer	0.000223	0.000597	CbGpPWpGaD
Acamprosate—GRIN2B—BDNF signaling pathway—AKT1—liver cancer	0.000221	0.000593	CbGpPWpGaD
Acamprosate—GABRB3—Neuronal System—BRAF—liver cancer	0.000217	0.000582	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—JUN—liver cancer	0.000216	0.00058	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—CTNNB1—liver cancer	0.000215	0.000575	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—PPARG—liver cancer	0.000214	0.000574	CbGpPWpGaD
Acamprosate—GABRG2—Neuronal System—BRAF—liver cancer	0.000213	0.000572	CbGpPWpGaD
Acamprosate—GRIN2D—Neuronal System—HRAS—liver cancer	0.000211	0.000567	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—PPARG—liver cancer	0.000209	0.00056	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—MMP9—liver cancer	0.000207	0.000555	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—CYCS—liver cancer	0.000207	0.000554	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—IL2—liver cancer	0.000206	0.000553	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—TERT—liver cancer	0.000206	0.000551	CbGpPWpGaD
Acamprosate—GABRA1—Transmission across Chemical Synapses—RAF1—liver cancer	0.000203	0.000545	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—CYCS—liver cancer	0.000203	0.000544	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—MMP9—liver cancer	0.000202	0.000541	CbGpPWpGaD
Acamprosate—GRIN1—Transmission across Chemical Synapses—HRAS—liver cancer	0.000198	0.00053	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—MMP2—liver cancer	0.000197	0.000527	CbGpPWpGaD
Acamprosate—GRIN2B—Transmission across Chemical Synapses—HRAS—liver cancer	0.000193	0.000516	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—MMP2—liver cancer	0.000192	0.000514	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—VEGFA—liver cancer	0.000189	0.000506	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—KDR—liver cancer	0.000188	0.000504	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—MAPK14—liver cancer	0.000187	0.000501	CbGpPWpGaD
Acamprosate—GABRA1—Neuronal System—BRAF—liver cancer	0.000186	0.0005	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—VEGFA—liver cancer	0.000186	0.000498	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—ESR1—liver cancer	0.000183	0.000491	CbGpPWpGaD
Acamprosate—GABRB3—Neuronal System—RAF1—liver cancer	0.000181	0.000486	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—VEGFA—liver cancer	0.000181	0.000486	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—F2—liver cancer	0.000181	0.000485	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—HMOX1—liver cancer	0.00018	0.000482	CbGpPWpGaD
Acamprosate—GABRG2—Neuronal System—RAF1—liver cancer	0.000178	0.000478	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—CYCS—liver cancer	0.000177	0.000475	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—HMOX1—liver cancer	0.000176	0.000473	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—RAF1—liver cancer	0.000174	0.000467	CbGpPWpGaD
Acamprosate—GRIN2A—Neuronal System—HRAS—liver cancer	0.000174	0.000465	CbGpPWpGaD
Acamprosate—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—liver cancer	0.000173	0.000465	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PIK3CG—liver cancer	0.000173	0.000464	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—APC—liver cancer	0.000173	0.000464	CbGpPWpGaD
Acamprosate—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—liver cancer	0.00017	0.000457	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—RAF1—liver cancer	0.00017	0.000455	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—HRAS—liver cancer	0.00017	0.000455	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—BRAF—liver cancer	0.000163	0.000436	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—TNF—liver cancer	0.000162	0.000434	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—KRAS—liver cancer	0.000158	0.000424	CbGpPWpGaD
Acamprosate—GABRA1—Neuronal System—RAF1—liver cancer	0.000156	0.000417	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—HMOX1—liver cancer	0.000154	0.000413	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—KRAS—liver cancer	0.000154	0.000413	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PIK3CD—liver cancer	0.000152	0.000408	CbGpPWpGaD
Acamprosate—GRIN1—Neuronal System—HRAS—liver cancer	0.000151	0.000406	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—PIK3CA—liver cancer	0.000151	0.000404	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—CTNNB1—liver cancer	0.000151	0.000404	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—SERPINE1—liver cancer	0.000151	0.000404	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—AKT1—liver cancer	0.00015	0.000401	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—KRAS—liver cancer	0.000149	0.0004	CbGpPWpGaD
Acamprosate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—liver cancer	0.000149	0.000399	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—MMP9—liver cancer	0.000148	0.000396	CbGpPWpGaD
Acamprosate—GRIN2B—Neuronal System—HRAS—liver cancer	0.000148	0.000396	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—CTNNB1—liver cancer	0.000147	0.000394	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—PPARA—liver cancer	0.000145	0.000389	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—MMP9—liver cancer	0.000144	0.000386	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—PPARA—liver cancer	0.000142	0.000382	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—PIK3CA—liver cancer	0.000137	0.000367	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—RAF1—liver cancer	0.000136	0.000364	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—HRAS—liver cancer	0.000134	0.00036	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PIK3CB—liver cancer	0.000133	0.000356	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—MTOR—liver cancer	0.000133	0.000356	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—VEGFA—liver cancer	0.000133	0.000356	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—STAT3—liver cancer	0.000131	0.000352	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—HRAS—liver cancer	0.000131	0.000351	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—IL6—liver cancer	0.000131	0.00035	CbGpPWpGaD
Acamprosate—GABRB3—Transmission across Chemical Synapses—HRAS—liver cancer	0.00013	0.00035	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—VEGFA—liver cancer	0.000129	0.000347	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—IL6—liver cancer	0.000129	0.000345	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—STAT3—liver cancer	0.000128	0.000343	CbGpPWpGaD
Acamprosate—GABRG2—Transmission across Chemical Synapses—HRAS—liver cancer	0.000128	0.000343	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—HRAS—liver cancer	0.000127	0.00034	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—IL6—liver cancer	0.000125	0.000336	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—PPARA—liver cancer	0.000125	0.000334	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CDKN1B—liver cancer	0.000125	0.000334	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—AKT1—liver cancer	0.000123	0.00033	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CASP3—liver cancer	0.000122	0.000327	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—IL2—liver cancer	0.000122	0.000327	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—TGFB1—liver cancer	0.000122	0.000326	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—IL6—liver cancer	0.000121	0.000325	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CCND1—liver cancer	0.000119	0.000319	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—TGFB1—liver cancer	0.000119	0.000318	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—JUN—liver cancer	0.000119	0.000318	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CTNNB1—liver cancer	0.000118	0.000315	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—MMP9—liver cancer	0.000115	0.000309	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CDKN1A—liver cancer	0.000115	0.000308	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—TNF—liver cancer	0.000114	0.000305	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—KRAS—liver cancer	0.000113	0.000302	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—MAPK8—liver cancer	0.000112	0.000301	CbGpPWpGaD
Acamprosate—GABRA1—Transmission across Chemical Synapses—HRAS—liver cancer	0.000112	0.0003	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—AKT1—liver cancer	0.000112	0.0003	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—TNF—liver cancer	0.000111	0.000297	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—KRAS—liver cancer	0.00011	0.000295	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—ALB—liver cancer	0.000108	0.000289	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—ALB—liver cancer	0.000106	0.000284	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—VEGFA—liver cancer	0.000104	0.000278	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—STAT3—liver cancer	0.000103	0.000275	CbGpPWpGaD
Acamprosate—GABRB3—Neuronal System—HRAS—liver cancer	9.99e-05	0.000268	CbGpPWpGaD
Acamprosate—GABRG2—Neuronal System—HRAS—liver cancer	9.81e-05	0.000263	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—RAF1—liver cancer	9.75e-05	0.000261	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—HRAS—liver cancer	9.58e-05	0.000257	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—RAF1—liver cancer	9.57e-05	0.000257	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—MYC—liver cancer	9.53e-05	0.000255	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—TGFB1—liver cancer	9.5e-05	0.000255	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—HRAS—liver cancer	9.34e-05	0.000251	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—ALB—liver cancer	9.25e-05	0.000248	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—IL6—liver cancer	9.17e-05	0.000246	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—IL6—liver cancer	8.94e-05	0.00024	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—KRAS—liver cancer	8.8e-05	0.000236	CbGpPWpGaD
Acamprosate—GABRA1—Neuronal System—HRAS—liver cancer	8.57e-05	0.00023	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—AKT1—liver cancer	8.46e-05	0.000227	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—RAF1—liver cancer	8.37e-05	0.000224	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—AKT1—liver cancer	8.25e-05	0.000221	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PIK3CA—liver cancer	8.09e-05	0.000217	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—TP53—liver cancer	7.82e-05	0.00021	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—HRAS—liver cancer	7.48e-05	0.000201	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—IL6—liver cancer	7.16e-05	0.000192	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—AKT1—liver cancer	6.61e-05	0.000177	CbGpPWpGaD
